Enterosorbent intervention therapies for populations at risk for Aflatoxin related diseases

CRSP:   |  Region:   |  Topic:   |  Database:
Details

Project Code:
TAM149

Start Date:
2008/01/01

End Date:
2012

CRSP Phase:
Phase 3

Budget:
Not Available

Countries:

Participants

Lead University:

Other Partners:
University of Alabama, University of Georgia (US); University of Science & Technology - Kumasi, Noguchi Memorial Medical Research Institute (Ghana)

Principal Investigator(s):
Tim Phillips

Co-Principal Investigator(s):
Pauline Jolly, Jia-Sheng Wang

Links
Overview

Aflatoxins (AFs) are harmful by-products of mold growth that can be fatal to humans and animals. The problem is longstanding, unavoidable and seemingly inextricable. A recent outbreak of AF poisoning in Kenya resulted in a 39% case fatality rate and was linked to consumption of foods containing AF levels as high as 8,000 ppb (CDC 2004). The poorest people in developing countries, who are most likely to consume foods contaminated with AFs, suffer the most severe effects including disease (aflatoxicosis) and even death following acute exposure (Lewis et al. 2005). Additionally, it is estimated that more than 80% of all hepatocellular cancer cases occur in developing countries (Wild and Hall 2000). Studies also suggest that low level exposure to AFs can cause immunosuppression and increased susceptibility to disease (Turner et al. 2003; Jiang et al. 2005). Other consequences of exposure include severe growth faltering and antinutritional effects (Hinton et al. 2003; Gong et al. 2002, 2004; Turner et al. 2007). Thus, feasible interventions and therapies to diminish human exposure to AFs are imperative. In this proposal, studies will provide an innovative and culturally acceptable strategy that will improve aflatoxicosis prevention and management in high risk populations (Ghana, etc.) by utilizing NS clay (i.e., capsules, tablets, powder, or food additives) to reduce human exposure and disease.

Objectives

Coming soon

Outcomes

Coming soon

Send us your questions or comments

Your Name (required)

Your Email (required)

Comment

Please enter this text:
captcha

[current-page]